2020 August Edition 47 | Page 22

www.AmericanSecurityToday.com 2020 - Edition 47 The U.S. government has invested over $5B in COVID-19 vaccines, creating a race to the fin- ish in the Biopharma industry, many of which rely on Aeroturn high performance turnstiles to secure against unauthorized access, corporate espionage, vaccine protestors, product tampering, and leaked information. Securing Access for Vaccine Big Pharma in a COVID-19 World Guest Editorial by Monique Merhige, President, Infusion Direct Marketing With the COVID-19 global pandemic on the rise and no end in sight, the Biopharma industry has received billions in US government funding to push the development of a COVID vaccine forward. The race is on as drug makers across the country work diligently to develop vaccines and therapies to help fight the COVID-19 battle. The U.S. government will pay $1.95 billion to buy 100 million doses of a COVID-19 vaccine being developed by Pfizer Inc. and German biotech BioN 22